The Diagnosis That Took Years
For many families of children with severe neurodevelopmental conditions, the hardest part isn't the seizures, the delays, or the long hospital stays. It's the not knowing.
Why did this happen? Was there something we could have done? Will our next child be affected? For families without a diagnosis, every question comes back as a shrug.
Each new gene that scientists link to a disorder takes another set of families out of that limbo. This study adds one more gene — called WDR91 — to the growing list.
Severe neurodevelopmental disorders affect thousands of children. Some have well-known causes like Down syndrome or fragile X. But a large share remain mysteries, even after exhaustive testing. Advances in genetic sequencing over the last decade have changed that. Scientists can now scan every gene in a patient's DNA at once, looking for rare changes that no common test would catch.
The result has been a steady drip of new discoveries. Each one matters to just a handful of families at first — sometimes only one — but together, they're rewriting the map of what we know about brain development.
This study focuses on a single child. But the implications reach further.
The Child at the Center of the Story
The child in this report had a severe mix of symptoms. Their head stopped growing properly at the size expected for their age — a condition called microcephaly. Brain imaging showed that the usual folds and ridges of the outer brain layer hadn't formed correctly, a pattern called microlissencephaly. The corpus callosum, the thick cable of nerve fibers that lets the two halves of the brain talk to each other, was underdeveloped. And seizures started in the first months of life.
Standard genetic testing hadn't found an answer. So researchers looked deeper.
What They Found in the DNA
The child had two different changes in the same gene — one on the copy inherited from each parent. That pattern is called compound heterozygous. Both changes affected a gene called WDR91, which makes a protein most people have never heard of but their cells use constantly.
One change was severe enough that it essentially shut off that copy of the gene.
The other change was subtler. Instead of completely breaking the gene, it made the protein less stable — so it fell apart faster than it should. The end result: the child's cells were running low on WDR91 protein, and what little they had wasn't working properly.
Think of every cell in the body as a small, busy factory. Deliveries come in through the front door — tiny bubbles called endosomes that carry nutrients, signals, and raw materials. Inside, those bubbles have to mature step by step, being sorted, shifted, and eventually sent to the cell's recycling center.
WDR91 is like a shift supervisor on that factory floor. It helps bubbles grow up — mature from "early" to "late" — so they can be routed correctly. Without enough of it, the flow breaks down. Recycling slows. Important deliveries get lost. For a normal adult cell, that's a problem. For the rapidly growing cells of a developing brain, it's catastrophic.
The researchers also found that another important cellular cleanup process, called autophagy — literally "self-eating," the way cells break down and recycle their own worn-out parts — was disrupted too. Both systems depend on healthy trafficking between compartments. When WDR91 is missing, both stall.
The Evidence Behind the Claim
The researchers didn't stop at finding the gene changes. They tested them in cells grown from the child's own tissue. They confirmed that the WDR91 protein levels were low. They showed that in cell models, both gene changes caused the same traffic jam in endosome maturation. They found signs of autophagy dysfunction in the child's cells too.
Piecing all of this together gives something rare in a first gene discovery: a clear story not just of what broke, but why.
What This Means for Families
For families of children with unexplained severe neurodevelopmental disorders, findings like this are the slow, steady work of science closing the gaps. A new gene identified today means that somewhere, another child with a similar pattern of symptoms might now get a name for their condition. That matters for:
- Ending the diagnostic odyssey — years of tests, specialists, and waiting rooms.
- Family planning — understanding whether future children carry the same risk.
- Connecting families — finding others facing the same rare condition.
- Opening the door to treatment research — which can only happen once a cause is clear.
This report describes a single child. Every genetic finding of this size is considered preliminary until other children with similar variants are found and studied. It's possible that other cases will refine — or even revise — what we understand about this gene. The functional experiments strengthen the case, but they're done in lab-grown cells, not whole brains.
Most newly-discovered disease genes sit quietly for years before the next patient with the same condition is identified. That's changing as more labs share data through international databases. The next step is finding more families whose children carry changes in WDR91 and building a clearer picture of the full range of symptoms. Eventually, understanding the mechanism — the traffic jam in endosome maturation — could point toward targets for therapies.